Kasuistik interaktiv: Akute Vigilanzminderung nach einem Marathon – Atypische Manifestation einer Basilaristhrombose

 

 Buy Article Permissions and Reprints

Zusammenfassung

Wir berichten über eine 27 Jahre alte Patientin, die nach der Teilnahme an einem Marathon ein progressives neurologisches Defizit (Anisokorie, Dysarthrie und Fazialisparese) entwickelte. Nach endotrachealer Intubation wurde sie unter der Verdachtsdiagnose einer intrakraniellen Blutung in ein nahe liegendes Klinikum der Maximalversorgung transportiert. Die umgehend durchgeführte radiologische Bildgebung mittels Computertomografie und Angiografie zeigte das Bild einer akuten Basilaristhrombose. Die Patientin konnte zwei Stunden nach Auftreten der Symptomatik erfolgreich lysiert werden und erholte sich vollständig.

Abstract

We report on a 27-year-old female patient who developed a progressive neurological disorder (anisocoria, dysarthria and facial nerve paresis) after participating in a marathon race. She was admitted to a maximum care level hospital after endotracheal intubation with a provisional diagnosis of intracranial bleeding. Imaging studies (computed tomography and computed tomographic angiography) revealed basilar artery occlusion. A successful outcome was achieved following thrombolysis within two hours of the initial onset of symptoms.

Literatur:

• 1 Whitson BA, Nath DS, Knudtson JR, Shumway SJ. Cardiopulmonary bypass in revascularization and fluid management of exercise-induced acute myocardial infarction.  J Card Surg. 2006;  21 480-483
  CrossrefPubMedGoogle Scholar
• 2 Chan KL, Davies RA, Chambers RJ. Coronary thrombosis and subsequent lysis after a marathon.  J Am Coll Cardiol. 1984;  4 1322-1325
  CrossrefPubMedGoogle Scholar
• 3 Disdier P, Harle JR, Swiader L, Gambarelli-Mouillac N, Weiller PJ. Retinal vein occlusions in a marathon runner.  Presse Med. 1992;  21 582
  PubMedGoogle Scholar
• 4 Gaudard A, Varlet-Marie E, Monnier JF, Janbon Ch, Quere I, Bressolle F, Brun JF. Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report.  Clin Hemorheol Microcirc. 2002;  27 115-122
  PubMedGoogle Scholar
• 5 Scobie BA. Gastrointestinal emergencies with marathon-type running: omental infarction with pancreatitis and liver failure with portal vein thrombosis.  N Z Med J. 1998;  111 211-212
  PubMedGoogle Scholar
• 6 Amann W, Fruhwirth J, Schweiger W, Koch G. Isolated pelvic vein thrombosis in a young marathon runner.  Sportverletz Sportschaden. 1997;  11 33-34
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Thompson GR, Scott J, Walport MJ, Oakley CM, Hughes JMB, Bulpitt CJ, TaylorRobinson SD. Grand rounds – Hammersmith Hospital – Hazards of running a marathon: Creatine kinase MB can be raised without myocardial infarction.  BMJ. 1997;  314 1023-1025
  CrossrefPubMedGoogle Scholar
• 8 Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van EM Cott, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers.  Am J Clin Pathol. 2002;  118 856-563
  CrossrefPubMedGoogle Scholar
• 9 Kemmeren JM, Tanis BC, van der Bosch MA, Bollen EL, Helmerhorst FM, van de rGraaf Y, Rosendaal FR, Algra A. Risk of arterial thrombosis in relation to oral contraceptives (ratio) study: oral contraceptives and the risk of ischemic stroke.  Stroke. 2002;  33 1202-1208
  CrossrefPubMedGoogle Scholar
• 10 Brandt T. Diagnosis and thrombolytic therapy of acute basilar artery occlusion. A review.  Clin Exp Hypertens. 2002;  24 611-622
  CrossrefPubMedGoogle Scholar
• 11 Fagerhol MK, Nielsen HG, Vetlesen A, Sandvik K, Lyberg T. Increase in plasma calprotectin during long-distance running.  Scand J Clin Lab Invest. 2005;  65 211-220
  CrossrefPubMedGoogle Scholar
• 12 Hanke A, Staib A, Goerlinger K, Perrey M, Dirkmann D, Kienbaum P. Whole blood coagulation and platelet activation in the athlete: a comparison of marathon, triathlon and long distance cycling.  Eur J Med Res. 2010;  15 59-65
  CrossrefPubMedGoogle Scholar
• 13 The European Stroke Initiative Executive Committee and the EUSI Writing Committee . European Stroke Initiative recommendations for stroke management –Update 2003.  Cerebrovasc Dis. 2003;  16 311-337
  CrossrefPubMedGoogle Scholar
• 14 Seitz RJ, Siebler Platelet M.. GPIIb/IIIa-receptor antagonists in human ischemic brain disease.  Curr Vasc Pharmacol. 2008;  6 29-36
  CrossrefPubMedGoogle Scholar

Dr. med. Timur Sellmann
Dr. med. Peter Noetges

Email: timur.sellmann@med.uni-duesseldorf.de

Email: peter.noetges@helios-kliniken.de

• Supplementary Material